Combination of Chemotherapy and ALK Inhibitors in ALK-Positive NSCLC. De Carlo E, Schiappacassi M, Del Conte A, Stanzione B, et al. J Thorac Oncol 2021;16:e31-e32.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

De Carlo E, Schiappacassi M, Del Conte A, Stanzione B, et al. Combination of Chemotherapy and ALK Inhibitors in ALK-Positive NSCLC. J Thorac Oncol 2021;16:e31-e32.
PMID: 33896577